Calciumantagonisten versus conventionele middelen bij hypertensie

1. Brown MJ, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366-372.
2. MacMahon S, et al. Differences between blood-pressure-lowering drugs [commentaar]. Lancet 2000; 356: 352-353.
3. Hansson L, et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000; 356: 359-365.